Abstract:Purpose: Propofol infusion is a popular single drug of choice for sedation in the gastrointestinal endoscopy suite. Drug combinations are more beneficial than single-drug regimens in gastroscopy sedation. However, the cardiopulmonary complications of propofol sedation raise concern. Remimazolam is a novel, ultra-short-acting benzodiazepine sedative, and alfentanil is a weak opioid. During endoscopic procedures, remimazolam is an effective and safe sedative procedure. No synergistic effect has been reported when remimazolam was combined with alfentanil in gastroscopy sedation. Here, we evaluated the effective dose, sedative efficacy, and safety of the remimazolam-alfentanil combination in gastroscopy sedation and compared the results with those of the propofol-alfentanil combination. Methods: This study was conducted in two parts. In Part 1, Dixon's up-and-down method (sequential distribution) was adopted for determining the 95% effective dose (ED95) (95% CI) and 95% CI of remimazolam combined with 5 µg/kg alfentanil. In Part 2, after obtaining the predictive remimazolam ED95, 161 patients were randomized into the remimazolam group (remimazolam-alfentanil) and the propofol group (propofol-alfentanil). The effectiveness of the drug combinations was measured according to successful sedation parameters. Changes in vital signs and the appearance of adverse events were used to assess the safety of drug combinations. Evaluation of patient and physician satisfaction was included as quality indicators of treatment. Results: Baseline demographic and clinical characteristics were comparable between the 2 parts of the study. The ED95 of remimazolam in inhibiting a positive response to gastroscopy placement into the pharyngeal cavity was 0.33 mg/kg (95% CI, 0.289 to 1.023). The procedure success rate was 97.53% in the remimazolam group and 97.50% in the propofol group. The difference in the success rate of the procedure between the remimazolam and propofol groups was 0.03% (95% CI, -2.5 to 2.4). However, the incidence of injection pain, hypotension, respiratory depression, and dizziness was lower in the remimazolam group compared with the propofol group (P < 0.05). Furthermore, patients from the propofol group were more likely to be drowsy, and their work efficiency was reduced the day after leaving the hospital, whereas patients in the remimazolam group were less affected (P < 0.05). Implications: The ED95 of remimazolam was 0.33 mg/kg when it was combined with alfentanil (5 µg/kg) for gastroscopy sedation. The sedation strategy of remimazolam-alfentanil has noninferior efficacy, fewer adverse effects, and a better postoperative recovery process than propofol-alfentanil for patients undergoing gastroscopy. Chinese Clinical Trials Registry identifier: ChiCTR2100051565.

Associated sedation of propofol and midazolam in small dosage and gastroscopy

[Effect of Various Uses of Propofol on the Upper Gastrointestinal Endoscopy].

Optimizing sedation in gastroscopy: a study on the etomidate/propofol mixture ratio

Sedation and Safety of Propofol for Therapeutic Endoscopic Retrograde Cholangiopancreatography.

[Propofol Combined with Midazolam Intravenous Sedation Anesthesia in Pediatric Upper Gastrointestinal Endoscopy].

Comparison of application of different etomidate-propofol concentrations for painless gastroscopy

Efficacy and Safety of Propofol combined with different doses of Remifentanil for gastroscopy: A-randomized controlled trial

Comparison of 95% Effective Dose of Remimazolam Besylate and Propofol for Gastroscopy Sedation on Older Patients: A Single‐centre Randomized Controlled Trial

The effectiveness of esketamine and propofol versus dezocine and propofol sedation during gastroscopy: A randomized controlled study

Propofol Anesthesia with Midazolam in the Elderly Patients Undergoing Gastroscopy

Propofol Alone Versus Propofol in Combination with Remifentanil or Ketamine for Analgesia during Gastroscopy and Colonoscopy.

The comparison of different inserting time on patients under propofol combined sufentanil anesthesia in gastroscopy

Anesthesia Effect of Dexmedetomidine Combined with Propofol in Gastroscopy

Comparison of propofol-esketamine versus propofol for anesthesia in gastroscopy: a double-blind, randomized controlled clinical trial

Continuous infusion of propofol combined with midazolam for patients undergoing long-time microsurgeries

Sedation with a 1:1 mixture of etomidate and propofol for gastroscopy in hypertensive elderly patients

Safety and Risk Factors of Propofol for Conscious Sedation During in Gastrocopy

Efficacy and Safety of the Remimazolam-Alfentanil Combination for Sedation During Gastroscopy: A Randomized, Double-blind, Single-center Controlled Trial

Safety and effectiveness of the combination of remimazolam tosilate and propofol in gastroscopy: a multicenter, randomized controlled, single-blind clinical trial

Propofol and remifentanil applied in gastroscopy

Clinical Observation of the Combined Use of Propofol and Etomidate in Painless Gastroscopy.